Serum soluble Fas levels and prediction
β
Parvesh Chaudhry; Radhika Srinivasan; Firuza D Patel; Sarala Gopalan; Siddhartha
π
Article
π
2007
π
John Wiley and Sons
π
French
β 199 KB
π 1 views
## Abstract Epithelial ovarian cancer (EOC) is treated mainly by platinumβbased combination chemotherapy. Chemotherapy induces apoptosis in which the Fas/Fas ligand pathway is important. Serum soluble Fas (sFas) is a biomarker of this pathway and functionally inhibits Fasβ/FasLβmediated apoptosis.